Study Links Popular Cardiovascular Drugs To Suicide
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Study Links Popular Cardiovascular Drugs To Suicide

LONDON, ENGLAND -- March 6, 1998 -- In a study including 152 Swedish municipalities (total population of 7.3 million), Dr. Anne Melander, professor of pharmacoepidemiology, Swedish Network for Pharmacoepidemiology Foundation, Malm University Hospital in Sweden, and colleagues investigated possible associations between the use of cardiovascular drugs and suicide and the results of this study are published in this week's British Medical Journal.

The authors found a significant correlation between the use of calcium channel blockers and the incidence of suicide (that remained significant when differences in cardiovascular morbidity were considered).

Furthermore, in a five year study of drugs for high blood pressure, the authors found a five-fold increase in the incidence of suicide in users of calcium channel blockers compared with users of other antihypertensives.

Among the Swedish municipalities the use of each cardiovascular drug group except angiotensin converting enzyme inhibitors correlated significantly and positively with suicide rates. After adjustment for the use of other cardiovascular drug groups, as a substitute for the prevalence of cardiovascular morbidity, only the correlation with calcium channel blockers remained significant.

In the cohort study, five users and four non-users of calcium channel blockers committed suicide during the follow up until the end of 1994. The absolute risk associated with use of calcium channel blockers was 1.1 suicides per 1,000 person years. The relative risk, adjusted for differences in age and sex, among users versus non-users was 5.4.

The researchers conclude that calcium channel blockers should be considered a possible cause of depression and suicide.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities